Mr. Ibrahem/Butoconazole
Clinical data
Trade namesGynazole-1, Femstat-3, others
AHFS/Drugs.comMonograph
MedlinePlusa682012
License data
Pregnancy
category
  • AU: B3
Routes of
administration
Vaginal cream
Drug classAntifungal[1]
Legal status
Legal status
  • US: OTC / Rx-only
Identifiers
  • (RS)-1-[4-(4-Chlorophenyl)-2-(2,6-dichlorophenyl)sulfanylbutyl]imidazole
Chemical and physical data
FormulaC19H17Cl3N2S
Molar mass411.77 g·mol−1
3D model (JSmol)
  • Clc1ccc(cc1)CCC(Sc2c(Cl)cccc2Cl)Cn3ccnc3
  • InChI=1S/C19H17Cl3N2S/c20-15-7-4-14(5-8-15)6-9-16(12-24-11-10-23-13-24)25-19-17(21)2-1-3-18(19)22/h1-5,7-8,10-11,13,16H,6,9,12H2 checkY
  • Key:SWLMUYACZKCSHZ-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Butoconazole, sold under the brand name Gynazole-1 among others, is antifungal used to treat vaginal yeast infections.[1] It is used inside the vagina.[1]

Common side effects include burning, itchiness, and abdominal pain.[1] Its use may weaken condoms in the 3 days following application.[1] It may be used in pregnancy.[1] It is an imidazole.[1]

Butoconazole was first made in 1978 and approved for medical use in the United States in 1995.[2][1] It is available over the counter.[1] In the United States a dose costs about 105 USD as of 2022.[3]

References

edit
  1. ^ a b c d e f g h i j k "Butoconazole Monograph for Professionals". Drugs.com. Archived from the original on 3 January 2022. Retrieved 12 January 2022.
  2. ^ Grayson, M. Lindsay; Crowe, Suzanne M.; McCarthy, James S.; Mills, John; Mouton, Johan W.; Norrby, S. Ragnar; Paterson, David L.; Pfaller, Michael A. (29 October 2010). Kucers' The Use of Antibiotics Sixth Edition: A Clinical Review of Antibacterial, Antifungal and Antiviral Drugs. CRC Press. p. 1893. ISBN 978-1-4441-4752-0. Archived from the original on 12 January 2022. Retrieved 12 January 2022.
  3. ^ "Gynazole-1 Prices, Coupons & Savings Tips - GoodRx". GoodRx. Archived from the original on 29 October 2016. Retrieved 12 January 2022.